INSIDER · CIK 1882909
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics, Inc. (TVTX)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$335KSold on the market
1Companies
Sep 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202621:29 | Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | S · Sell10b5-1 | $62.33 | −5,375 | 42,353 | -11% | −$335K | ||
| Sep 17, 202621:29 | Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | M · Exercise10b5-1 | $24.19 | +5,375 | 47,728 | +13% | $130K |